A new inhaler that treats chronic obstructive pulmonary disease (COPD) and also helps reduce environmental harm has been approved for use in the UK. This inhaler is already available in India.

Pharmaceutical company AstraZeneca is beginning a clinical trial in collaboration with Quintiles looking at the impact of mobile medication reminders for people with chronic obstructive pulmonary ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the world’s first low-carbon version of a triple-combination inhaler for chronic obstructive pulmonary disease (COPD). The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Inhaled corticosteroids are often used outside of the ...

Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study. The study is published in the May 2025 issue of Chronic ...

Please provide your email address to receive an email when new articles are posted on . The ProAir Digihaler captured peak inspiratory flow, inhalation volume, inhalation duration, time to peak ...

A new study finds that a sensor-equipped "smart inhaler" can accurately track how—and how well—COPD patients use their medication at home, offering clinicians real-time insights into patient behavior ...

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study - the largest to date quantifying inhaler-related ...

Inhalers that provide fast-acting treatment for people with certain respiratory conditions are contributing to greenhouse gas emissions, which can worsen both climate change and the conditions ...

Inhalers that deliver quick relief to patients with asthma and chronic obstructive pulmonary disease (COPD) may be taking a toll on the planet, producing as much climate-warming pollution as more than ...

“Inhalers produce as much carbon emissions as half a million cars each year.” That’s how headlines read after a startling new JAMA analysis revealed that the 160 million inhalers dispensed in the US ...

Nov. 26 -- TUESDAY, Nov. 25 (HealthDay News) -- A new review of existing data confirms that some common inhalers don't boost the life spans of people with the lung disease known as chronic obstructive ...